Peptide V3 Inhibits the Growth of Human Hepatocellular Carcinoma by Inhibiting the Ras/Raf/MEK/ERK Signaling Pathway

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths. Peptide V3 has shown anti-angiogenic and anti-tumor effects on S180 and H22 xenografts in nude mice. However, the detailed mechanism of action of peptide V3 has not yet been fully elucidated. In the present study,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Cancer
Hauptverfasser: Wu, Dongdong, Li, Mengling, Gao, Yingran, Tian, Wenke, Li, Jianmei, Zhang, Qianqian, Liu, Zhengguo, Zheng, Mengli, Wang, Hongju, Wang, Jun, Teng, Tieshan, Zhang, Lei, Ji, Xinying, Xie, Zhongwen, Ji, Ailing, Li, Yanzhang
Format: Artigo
Sprache:Inglês
Veröffentlicht: Ivyspring International Publisher 2019
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548006/
https://ncbi.nlm.nih.gov/pubmed/31205525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.29211
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge